作者: Olivier Glehen , Dimitri Osinsky , Annie Claude Beaujard , François Noël Gilly , None
DOI: 10.1016/S1055-3207(03)00044-9
关键词:
摘要: Both clinical experience and research show that there is a limited survival, estimated to be approximately 6 months, in patients with peritoneal carcinomatosis from nongynecologic malignancy. Survival shortest pancreas cancer, slightly more prolonged colon cancer. The short survival seen when the diagnosis of made synchronously primary also it diagnosed follow-up. A large diagnostic shortcoming inability reliably diagnose carcinomatosis, either malignancy or recurrent Gilly staging system has profound prognostic implications this group patients. rapid progression disease state dependence benefit upon complete cytoreduction suggests need for early interventions selected